Literature DB >> 19138790

The presence of gamma' chain impairs fibrin polymerization.

Kathryn C Gersh1, Chandrasekaran Nagaswami, John W Weisel, Susan T Lord.   

Abstract

INTRODUCTION: A fraction of fibrinogen molecules contain an alternatively spliced variant chain called gamma'. Plasma levels of this variant have been associated with both myocardial infarction and venous thrombosis. Because clot structure has been associated with cardiovascular risk, we examined the effect of gamma' chain on clot structure.
MATERIALS AND METHODS: We expressed three fibrinogen variants in Chinese hamster ovary (CHO) cells: gamma/gamma homodimer, gamma/gamma' heterodimer, and gamma'/gamma' homodimer. We observed thrombin-catalyzed fibrinopeptide release by HPLC, fibrin polymerization by turbidity, and clot structure by scanning electron microscopy. We characterized post-translational modifications by mass spectrometry.
RESULTS: Fibrinopeptide A was released at the same rate for all three fibrinogens, while fibrinopeptide B was released faster from the gamma'/gamma' homodimer. The rise in turbidity was slower and final absorbance was lower during polymerization of gamma'-containing fibrinogens than for gamma/gamma fibrinogen. Micrographs showed that gamma'/gamma' fibrin clots are composed of very thin fibers, while the diameter of gamma/gamma' fibers is similar to gamma/gamma fibers. Further, the fiber networks formed from gamma'-containing samples were non-uniform. Mass spectrometry showed heterogeneous addition of N-glycans and tyrosine sulfation in the gamma' chain.
CONCLUSIONS: The presence of gamma' chains slows lateral aggregation and alters fibrin structure. We suggest these changes are likely due to charge-charge repulsion, such that polymerization of the gamma'/gamma' homodimer is more impaired than the heterodimer since these repulsions are partially offset by incorporation of gamma chains in the gamma/gamma' heterodimer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138790      PMCID: PMC2752440          DOI: 10.1016/j.thromres.2008.11.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  33 in total

1.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Authors:  J P Collet; D Park; C Lesty; J Soria; C Soria; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled.

Authors:  J W Weisel; C Nagaswami
Journal:  Biophys J       Date:  1992-07       Impact factor: 4.033

3.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

4.  The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen.

Authors:  O V Gorkun; Y I Veklich; J W Weisel; S T Lord
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

5.  Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma').

Authors:  C Wolfenstein-Todel; M W Mosesson
Journal:  Biochemistry       Date:  1981-10-13       Impact factor: 3.162

6.  Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors.

Authors:  M N Mannila; R S Lovely; S C Kazmierczak; P Eriksson; A Samnegård; D H Farrell; A Hamsten; A Silveira
Journal:  J Thromb Haemost       Date:  2007-01-22       Impact factor: 5.824

7.  Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of gammaAla327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism.

Authors:  Akiei Hamano; Jun Mimuro; Motonori Aoshima; Takeyoshi Itoh; Noboru Kitamura; Susumu Nishinarita; Katsuhiro Takano; Akira Ishiwata; Yuji Kashiwakura; Kazuki Niwa; Tomoko Ono; Seiji Madoiwa; Teruko Sugo; Michio Matsuda; Yoichi Sakata
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

8.  Fibrinogen gamma' in ischemic stroke: a case-control study.

Authors:  Elim Y L Cheung; Shirley Uitte de Willige; Hans L Vos; Frank W G Leebeek; Diederik W J Dippel; Rogier M Bertina; Moniek P M de Maat
Journal:  Stroke       Date:  2008-01-31       Impact factor: 7.914

9.  Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.

Authors:  Rehana S Lovely; Lynn K Boshkov; Ulla M Marzec; Stephen R Hanson; David H Farrell
Journal:  Br J Haematol       Date:  2007-11       Impact factor: 6.998

10.  Identification and characterization of the thrombin binding sites on fibrin.

Authors:  D A Meh; K R Siebenlist; M W Mosesson
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

View more
  16 in total

1.  Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease.

Authors:  Rehana S Lovely; Steven C Kazmierczak; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; David H Farrell
Journal:  Clin Chem       Date:  2010-03-26       Impact factor: 8.327

2.  Association between γ' fibrinogen levels and inflammation.

Authors:  Kristine S Alexander; Theresa E Madden; David H Farrell
Journal:  Thromb Haemost       Date:  2010-12-21       Impact factor: 5.249

3.  Assessment of genetic determinants of the association of γ' fibrinogen in relation to cardiovascular disease.

Authors:  Rehana S Lovely; Qiong Yang; Joseph M Massaro; Jing Wang; Ralph B D'Agostino; Christopher J O'Donnell; Jackilen Shannon; David H Farrell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-14       Impact factor: 8.311

Review 4.  Mechanisms of fibrin polymerization and clinical implications.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

5.  Specific effects of fibrinogen and the γA and γ'-chain fibrinogen variants on angiogenesis and wound healing.

Authors:  Elim Y L Cheung; Ester M Weijers; Bastiaan Tuk; Reinilde Scheffer; Frank W Leebeek; Johan W van Neck; Pieter Koolwijk; Moniek P M de Maat
Journal:  Tissue Eng Part A       Date:  2014-08-05       Impact factor: 3.845

6.  Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.

Authors:  Paul Y Kim; Trang T Vu; Beverly A Leslie; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

7.  In vivo study of novelly formulated porcine-derived fibrinogen as an efficient sealant.

Authors:  Zhang Liu; Lidong Guan; Kang Sun; Xujun Wu; Ling Su; Jifeng Hou; Miao Ye; Weihong Huang; Hongbing He
Journal:  J Mater Sci Mater Med       Date:  2015-03-07       Impact factor: 3.896

Review 8.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

Review 9.  Fibrin mechanical properties and their structural origins.

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Matrix Biol       Date:  2016-08-20       Impact factor: 11.583

10.  The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits.

Authors:  James R Byrnes; Clare Wilson; Anthony M Boutelle; Chase B Brandner; Matthew J Flick; Helen Philippou; Alisa S Wolberg
Journal:  Blood       Date:  2016-08-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.